Nevada
Prescription drug spending and prescribing in Nevada, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $2.0B for prescriptions written in Nevada, the 35th most of 52 states and territories, and 4.7% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $2.0B
- Medicaid drugs, 2025: $870M
- Opioid share of claims: 4.7%
- Life-science raises, 2 years: $112M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Nevada | United States | Difference |
|---|---|---|---|
| Opioids | 4.7% | 3.5% | +32% |
| Antibiotics | 4.9% | 4.4% | +11% |
| Antipsychotics | 1.5% | 1.7% | -16% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Nevada's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Trihexyphenidyl Hcl | 2.4× | 3,382 |
| Carisoprodol | 2.2× | 5,383 |
| Sildenafil Citrate | 2.0× | 11,858 |
| Ibuprofen | 1.9× | 99,150 |
| Indomethacin | 1.9× | 3,451 |
| Morphine Sulfate | 1.9× | 33,982 |
| Hepatitis A And B Vaccine/Pf | 1.9× | 3,834 |
| Megestrol Acetate | 1.8× | 6,196 |
| Insulin Glargine/Lixisenatide | 1.8× | 3,413 |
| Galantamine Hbr | 1.8× | 3,220 |
Biggest Medicaid Drugs
What Nevada's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
34 Form D raises by companies based in Nevada in the last two years; the 10 largest. See all raises- ENCOMPASS TECHNOLOGIES, INC.$40M · Biotech · May 19, 2025
- VOLITIONRX LTD$23M · Biotech · May 30, 2025
- NV MEDTECH, Inc.$21M · Other health care · Jun 8, 2026
- PharmaCyte Biotech, Inc.$7M · Biotech · Sep 4, 2025
- Magvation Inc.$6M · Other health care · Jun 8, 2026
- Conexeu Sciences Inc.$3M · Biotech · Nov 13, 2025
- Heligenics, Inc.$3M · Biotech · Jan 8, 2025
- Frontier Health LLC$2M · Biotech · May 14, 2025
- Conexeu Sciences Inc.$2M · Biotech · Apr 1, 2026
- Conexeu Sciences Inc.$1M · Biotech · Oct 21, 2026
State Attorney General Health-Care Cases
Antitrust cases Nevada joined, newest first; see every case- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- Connecticut et al. v. Teva Pharmaceuticals et al. Civ. Action No. (D.Conn. Dec. 15, 2016)2016 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- State of Nevada v. Universal Health Services, Inc., Alan B. Miller, and Psychiatric Solutions, Inc., No. 2:10-cv-01984 (D.Nev. 2010)2010 · Settled
- In re UnitedHealth Group Incorporated and Sierra Health Services, Inc., No. 2:08-CV-00233 (D. Nev. 2008)2008 · Settled
- Florida et al. v. Abbott Laboratories et al., No. 1:08-cv-00155-SLR (D.Del. 2007)2007 · Settled
- Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)2006 · Settled
- State of Colorado et al v. Warner Chilcott, 1:05-cv-02182 (D.D.C.2005)2005 · Settled
- Maryland et al. v. Perrigo Company, No. 1:04CV01398 (D.D.C. Aug. 17, 2004)2004 · Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG